skip to main content

We are fortunate to advise world-class, industry-leading companies, helping them tackle novel, complex issues and push the boundaries of technological progress. Our ability and confidence to go to trial is our core strength; our deep bench of experienced trial lawyers represents companies in their most significant matters, helping them protect their intellectual property and launch products. Our lawyers pair extensive experience in the courtroom and the boardroom with a thorough understanding of science and technology.

Recognition

Complex patent and scientific litigation matters have garnered particular praise and recognition for Paul, Weiss's intellectual property patent group. Honors have included:

  • The American Lawyer
    • "Big Suits" - General Electric Company v. Mitsubishi Heavy Industries et al. (2012)
    • "Big Suits" - Edwards Lifesciences et al. v. CoreValve et al. (2010)
    • "Big Suits" - Gillette v. Energizer Holdings (Schick) (2005)
  • Benchmark Litigation 2024
    • Top Ranked Firm - Intellectual Property (USA), ranked since 2010
    • Three National Practice Area Stars - Intellectual Property 
    • Three Local Litigation Stars - Intellectual Property, two in NY and one in DC
    • "40 and Under" - Intellectual Property (USA)
  • Chambers Global 2023
    • Top Ranked Firm - Intellectual Property (USA)
  • Chambers USA 2023
    • Leading Firm - Intellectual Property: Patent (NY)
    • Leading Firm - Intellectual Property: Litigation (DC)
    • One Ranked Practitioner - Intellectual Property: Patent (NY)
  • IAM 
    • Patent 1000 2023
      • Leading firm (NY)
      • Two Recommended Practitioners
    • IAM Global Leaders 2022 
      • Three Attorneys Practitioners
  • Financial Times
    • One practitioner was recognized by the Financial Times as one of ten finals for the “Legal Innovator” award for North America for their work handling many of the highest-stake cases in the biopharmaceutical sector.
    • Paul, Weiss ranked in the Top 15 in Financial Times' 2015 "Innovative Lawyers Report" in the United States, Canada and Mexico. Paul, Weiss is commended in the following categories: Expanding Clients Business; Enabling Clients Business; and Protecting Clients Business.
  • The Legal 500 US 2023
    • Leading firm - Patent Litigation: Full Coverage, ranked since 2012
  • Law360
    • One practitioner in 2016 received Law360's "MVP Award" in the area of Intellectual Property Law
    • Two practitioners received Law360's "MVP Award" in the area of Intellectual Property Law in 2014
  • The National Law Journal (NLJ)
    • One practitioner named "Winning Litigator" for involvement as lead counsel for Vanda Pharmaceuticals in patent infringement lawsuit against West-Ward Pharmaceuticals Inc. 
    • One practitioner among the 50 top professionals in the U.S. recognized as 2016 "Litigation Trailblazers" by The National Law Journal for their work representing Amgen Inc. in a precedent-setting infringement case in the Federal Circuit involving the first patent challenge under the Biologics Price Competition and Innovation Act.
    • Paul, Weiss was included in the 2014 edition of NLJ's "Top 100 Verdicts of the Year" for our involvement in Edwards Lifesciences' patent victory against Medtronic.
    • Paul, Weiss was named to NLJ's 2013 "Intellectual Property Hot List." The award recognizes firms' cases that often have billions of dollars at stake and patents involving impressive advancements in science and technology, including ground-breaking pharmaceuticals; the contents of the food we put on our tables; and the ways we communicate with each other.
  • U.S. News - Best Lawyers "Best Law Firms" 2024
    • "Best Law Firms"
      • Tier 1 Firm - Litigation: Patent (National & DC)
      • Tier 1 Firm - Litigation: Intellectual Property (National, NYC & DC)
    • The Best Lawyers in America
      • Five lawyers listed for Litigation: Intellectual Property, four in NY and one in DC
      • One lawyer listed for Litigation: Patent

© 2024 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy